I reported previously (Jun 2017) on Israeli biotech NewStem which is developing a stem cell platform to test cancer treatments in the lab before potentially wasting them on patients. NewStem has just received $4 million of funds from an unlikely source – Hollywood Media Corp.
$4 million to advance cancer resistance testing
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.